Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Boric Acid SCHEMBL11062603 | 1.00 | — | — | |
| Boric Acid SCHEMBL28632861 | 1.00 | LMNA (0.67) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL28634604 | 1.00 | LMNA (0.67) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL751501 | 1.00 | — | — | |
| Boric Acid SCHEMBL28596114 | 0.93 | LMNA (0.57) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL9697284 | 0.93 | — | — | |
| Boric Acid SCHEMBL27464198 | 0.87 | LMNA (0.50) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL2835168 | 0.82 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL1227700 | 0.82 | LMNA (1.00) | LMNATSHRTDP1 | |
| Boric Acid SCHEMBL2793475 | 0.82 | LMNA (1.00) | LMNATSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118645-A | Hot-melt double-sided adhesive tape and preparation method thereof | 湖南万祺科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| US-20230405136-A1 | New Combinations of Boron Compounds and Adjuvants for the Treatment of Pathophysiological Conditions and Cancer and for Muscle Regeneration | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED, M.P. (ES) | 2023-12-21 | — | — | US | claimed |
| EP-4221758-A1 | NEW COMBINATIONS OF BORON COMPOUNDS AND ADJUVANTS FOR THE TREATMENT OF PATHOPHYSIOLOGICAL CONDITIONS AND CANCER AND FOR MUSCLE REGENERATION | Consorcio Centro de Investigación Biomédica en Red M.P. (ES) | 2023-08-09 | — | — | EP | claimed |
| WO-2022069768-A1 | NEW COMBINATIONS OF BORON COMPOUNDS AND ADJUVANTS FOR THE TREATMENT OF PATHOPHYSIOLOGICAL CONDITIONS AND CANCER AND FOR MUSCLE REGENERATION | Consorcio Centro de Investigación Biomédica en Red, M.P. (ES) | 2022-04-07 | — | — | WO | claimed |
| EP-3978028-A1 | NEW COMBINATIONS OF BORON COMPOUNDS AND ADJUVANTS FOR THE TREATMENT OF PATHOPHYSIOLOGICAL CONDITIONS AND MUSCLE REGENERATION | Consorcio Centro de Investigación Biomédica en Red M.P. (ES) | 2022-04-06 | — | — | EP | claimed |
| CN-120118645-A | Hot-melt double-sided adhesive tape and preparation method thereof | 湖南万祺科技有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-120118645-A | Hot-melt double-sided adhesive tape and preparation method thereof | 湖南万祺科技有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-118165665-A | High-voltage insulating self-adhesive tape and preparation method thereof | 江苏瑞禧智能电力科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| US-20230405136-A1 | New Combinations of Boron Compounds and Adjuvants for the Treatment of Pathophysiological Conditions and Cancer and for Muscle Regeneration | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED, M.P. (ES) | 2023-12-21 | — | — | US | disclosed |
| EP-4221758-A1 | NEW COMBINATIONS OF BORON COMPOUNDS AND ADJUVANTS FOR THE TREATMENT OF PATHOPHYSIOLOGICAL CONDITIONS AND CANCER AND FOR MUSCLE REGENERATION | Consorcio Centro de Investigación Biomédica en Red M.P. (ES) | 2023-08-09 | — | — | EP | disclosed |
| WO-2022069768-A1 | NEW COMBINATIONS OF BORON COMPOUNDS AND ADJUVANTS FOR THE TREATMENT OF PATHOPHYSIOLOGICAL CONDITIONS AND CANCER AND FOR MUSCLE REGENERATION | Consorcio Centro de Investigación Biomédica en Red, M.P. (ES) | 2022-04-07 | — | — | WO | disclosed |
| EP-3978028-A1 | NEW COMBINATIONS OF BORON COMPOUNDS AND ADJUVANTS FOR THE TREATMENT OF PATHOPHYSIOLOGICAL CONDITIONS AND MUSCLE REGENERATION | Consorcio Centro de Investigación Biomédica en Red M.P. (ES) | 2022-04-06 | — | — | EP | disclosed |
| US-8722243-B2 | Material for use as electrolyte, lithium secondary battery electrolyte, lithium secondary battery employing the same, and novel lithium salt | THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) | 2014-05-13 | — | — | US | disclosed |
| EP-2587580-A1 | ELECTROLYTE MATERIAL, ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY USING SAME, AND NOVEL LITHIUM SALT | The Nippon Synthetic Chemical Industry Co., Ltd. (JP) | 2013-05-01 | — | — | EP | disclosed |
| US-20130089777-A1 | MATERIAL FOR USE AS ELECTROLYTE, LITHIUM SECONDARY BATTERY ELECTROLYTE, LITHIUM SECONDARY BATTERY EMPLOYING THE SAME, AND NOVEL LITHIUM SALT | THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) | 2013-04-11 | — | — | US | disclosed |
| US-8235118-B2 | Generating heated fluid | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-08-07 | — | — | US | disclosed |
| WO-2009009297-A2 | GENERATING HEATED FLUID | HALLIBURTON ENERGY SERVICES, INC. (US) | 2009-01-15 | — | — | WO | disclosed |
| US-20090008090-A1 | Generating Heated Fluid | HALLIBURTON ENERGY SERVICES, INC. | 2009-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230405136-A1 | New Combinations of Boron Compounds and Adjuvants for the Treatment of Pathophysiological Conditions and Cancer and for Muscle Regeneration | MUSK, MBNL1, MYOF | LMNA 2493/4885TSHR 1458/4885TDP1 2021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.